[go: up one dir, main page]

MX2021000020A - Composicion y metodo para tratar el dolor. - Google Patents

Composicion y metodo para tratar el dolor.

Info

Publication number
MX2021000020A
MX2021000020A MX2021000020A MX2021000020A MX2021000020A MX 2021000020 A MX2021000020 A MX 2021000020A MX 2021000020 A MX2021000020 A MX 2021000020A MX 2021000020 A MX2021000020 A MX 2021000020A MX 2021000020 A MX2021000020 A MX 2021000020A
Authority
MX
Mexico
Prior art keywords
composition
treat pain
pain
cannabidiol
tetrahydrocannabinol
Prior art date
Application number
MX2021000020A
Other languages
English (en)
Inventor
Harry Karelis
Original Assignee
Zelira Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zelira Therapeutics Operations Pty Ltd filed Critical Zelira Therapeutics Operations Pty Ltd
Publication of MX2021000020A publication Critical patent/MX2021000020A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se relaciona con una composición farmacéutica que comprende ?9-tetrahidrocannabinol (THC) y cannabidiol (CBD) y una fracción de terpenos obtenida por extracción de una planta de Cannabis y su uso en el tratamiento del dolor.
MX2021000020A 2018-07-03 2019-07-03 Composicion y metodo para tratar el dolor. MX2021000020A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018100924A AU2018100924A4 (en) 2018-07-03 2018-07-03 Composition and method for treating pain
PCT/AU2019/050700 WO2020006599A1 (en) 2018-07-03 2019-07-03 Composition and method for treating pain

Publications (1)

Publication Number Publication Date
MX2021000020A true MX2021000020A (es) 2021-05-27

Family

ID=63079646

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000020A MX2021000020A (es) 2018-07-03 2019-07-03 Composicion y metodo para tratar el dolor.

Country Status (13)

Country Link
US (1) US20220218650A1 (es)
EP (1) EP3817733A4 (es)
KR (1) KR20210071939A (es)
AU (2) AU2018100924A4 (es)
BR (1) BR112020027080A2 (es)
CA (1) CA3104742A1 (es)
CL (1) CL2020003368A1 (es)
CO (1) CO2021001061A2 (es)
IL (1) IL279748A (es)
MX (1) MX2021000020A (es)
PE (1) PE20211650A1 (es)
SG (1) SG11202013239RA (es)
WO (1) WO2020006599A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3031810A1 (en) 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition
BR112019026877A2 (pt) 2017-06-19 2020-06-30 Zelda Therapeutics Operations Pty Ltd composições para distúrbios do sono e tratamentos do mesmo
WO2020061687A1 (en) * 2018-09-28 2020-04-02 Visceral Therapeutics Inc. Pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions
CA3134108A1 (en) * 2019-03-21 2020-09-24 ZYUS Life Sciences US Ltd. Cannabinoid and application supported opioid tapering
KR102445087B1 (ko) 2019-05-03 2022-09-20 자이우스 라이프 사이언시스 아이엔씨. 통증 관리용 제형
US12178797B2 (en) 2019-05-03 2024-12-31 Zyus Life Sciences Inc. Formulation for pain management
US12220396B2 (en) 2019-05-03 2025-02-11 Zyus Life Sciences Inc. Formulation for pain management
WO2020232530A1 (en) * 2019-05-22 2020-11-26 Canopy Growth Corporation Cannabinoid-comprising compositions for management of pain
JP2023529476A (ja) * 2020-06-12 2023-07-10 ゼリラ セラピューティクス オペレーションズ ピーティーワイ リミテッド 慢性疼痛を治療するための組成物及び方法
CA3091622A1 (en) 2020-08-28 2022-02-28 Teresa Ann Hanlon Pain relieving formulations containing cannabis and methods of making same
KR102269823B1 (ko) * 2021-01-18 2021-06-28 주식회사 네이처센스 대마 추출물을 포함하는 대사성 질환의 예방 및 치료용 조성물
IL309776A (en) * 2021-07-01 2024-02-01 Ananda Scient Inc Methods of treating pain using cannabinoids
WO2023126934A1 (en) * 2021-12-29 2023-07-06 Canonic Ltd. Cannabis compositions for treating pain and inflammation related disorders
CN118613274A (zh) 2022-01-28 2024-09-06 维尔塔尼科有限公司 一种植物提取物的生产方法
JP2025504971A (ja) 2022-01-31 2025-02-19 バータニカル ゲーエムベーハー デルタ－９－テトラヒドロカンナビノールとテルペンを含む組成物
WO2024044145A1 (en) * 2022-08-23 2024-02-29 Tribu Hemp Llc Cannabinoid and terpene composition to be applied on an absorbent material.
WO2025027091A1 (en) 2023-08-01 2025-02-06 Vertanical GmbH Composition for use in treatment and/or prevention of chronic musculoskeletal pain including chronic low back pain, chronic non-specific low back pain, osteoarthritis or other chronic musculoskeletal pain conditions comprising delta-9-tetrahydrocannabinol and terpenes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
WO2014100231A1 (en) * 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
EP3193862B1 (en) * 2014-09-16 2023-10-18 Igc Pharma Ip, Llc Topical cannabinoid composition for treating arthritic pain
AU2015335997B2 (en) * 2014-10-21 2020-10-01 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
EP3247402A4 (en) * 2015-01-21 2018-08-08 Willinsky, Michael Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler
CA2952335A1 (en) * 2015-12-19 2017-06-19 Delta 9 Gardening B.V. Therapeutic delivery formulations and systems comprising cannabinoids and terpenes
WO2017158539A1 (en) * 2016-03-16 2017-09-21 Buzzelet Development And Technologies Ltd Terpene-enriched cannabinoid composition
CA3065167A1 (en) * 2017-05-31 2018-12-06 Phytecs, Inc. Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
EP3704263A4 (en) * 2017-10-30 2021-08-25 Endocanna Health, Inc. GRAPHIC USER INTERFACES FOR DETERMINING CUSTOMIZED ENDOCANNABINOID GENOTYPES AND RELATED RECOMMENDATIONS

Also Published As

Publication number Publication date
KR20210071939A (ko) 2021-06-16
AU2019297198B2 (en) 2022-12-08
EP3817733A1 (en) 2021-05-12
BR112020027080A2 (pt) 2021-03-30
AU2019297198A1 (en) 2021-01-28
CA3104742A1 (en) 2020-01-09
PE20211650A1 (es) 2021-08-24
US20220218650A1 (en) 2022-07-14
EP3817733A4 (en) 2022-05-04
AU2018100924A4 (en) 2018-08-09
CL2020003368A1 (es) 2021-08-13
WO2020006599A1 (en) 2020-01-09
IL279748A (en) 2021-03-01
SG11202013239RA (en) 2021-01-28
CO2021001061A2 (es) 2021-06-30

Similar Documents

Publication Publication Date Title
CO2021001061A2 (es) Composición y método para tratar el dolor
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CO2017004974A2 (es) Extractos de cannabis y métodos de preparación.
CO2021001057A2 (es) Composición y método para el ahorro de opioides
MX2018011348A (es) Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades.
PE20230607A1 (es) Composicion de cannabis
PE20200726A1 (es) Composicion de cannabis
MX2019015315A (es) Composiciones y tratamientos para el trastorno del sueño.
PE20200676A1 (es) Composicion de cannabis
MX2021008702A (es) Uso de cannabinoides en el tratamiento de las comorbilidades asociadas a la epilepsia.
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
MX2017015083A (es) Composiciones cosmeticas que comprenden e/z-bencilideno-5,6-dimeto xi-3,3-dimetilindan-1-ona.
CL2017001893A1 (es) Uso de prg4 como agente antiinflamatorio
PE20211694A1 (es) Metodos de purificacion de cannabinoides, composiciones y kits de los mismos
BR112016017612A2 (pt) Uso de um extrato de uma planta do gênero mentha da família lamiaceae
CL2022003507A1 (es) Composición y método para tratar el dolor crónico
CO2018014229A2 (es) Composición biopesticida para uso en prevención o minimizacion de la enfermedad de la planta
CO2021001059A2 (es) Composición de cannabinoides y método para tratar el ptsd y/o la ansiedad
NI201900004A (es) Composición vaginal comprendiendo una combinación de estrógeno y vitamina d.
CO2021012893A2 (es) Polímero superabsorbente y método para aumentar el contenido de azúcar en plantas
EA201991659A1 (ru) Композиция от кашля
MX2021008602A (es) Composicion para el tratamiento y/o prevencion de sintomas del tracto urinario inferior.
BR112018001693A2 (pt) composição farmacêutica para prevenção de queda de cabelo ou promoção de crescimento de cabelo, método para prevenir a queda de cabelo e método para promover o crescimento do cabelo
AR116986A1 (es) Composición cosmética, método para la producción de aceite y/o manteca de astrocaryum vulgare, uso de la composición cosmética y método para la producción y/o protección contra la degradación del ácido hialurónico en la piel
CL2021001076A1 (es) Composición farmacéutica que comprende una combinación de 1,3-2,5% de tetrahidrocannabinol (thc) y 0,6-1,4% de cannabidiol (cbd); su proceso de elaboración; y su uso para el tratamiento del dolor crónico refractario.